NCT02965781View on ClinicalTrials.gov

Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 20, 2018

Study Completion Date

December 20, 2018

Conditions

Herpes LabialisCold Sore

Interventions

DRUG

SADBE

Topical solution

OTHER

Placebo

Topical solution

Trial Locations (5)

10468

Advantage Clinical Trials, The Bronx

33166

International Research Partners, LLC, Doral

68114

Quality Clinical Research, Inc, Omaha

94063

Stanford Medicine Outpatient Center, Redwood City

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Squarex, LLC

INDUSTRY

NCT02965781 - Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis | Biotech Hunter | Biotech Hunter